These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12375309)

  • 1. Rheumatoid arthritis: time for trials of therapeutic targets.
    Edmonds J; Lassere M
    J Rheumatol; 2002 Oct; 29(10):2041-4. PubMed ID: 12375309
    [No Abstract]   [Full Text] [Related]  

  • 2. Achieving tight control in rheumatoid arthritis.
    van Hulst LT; Hulscher ME; van Riel PL
    Rheumatology (Oxford); 2011 Oct; 50(10):1729-31. PubMed ID: 21933791
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased adiponectin levels in women with rheumatoid arthritis after etanercept treatment.
    Lewicki M; Kotyla P; Kucharz E
    J Rheumatol; 2009 Jun; 36(6):1346-7; author reply 1347. PubMed ID: 19509093
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology of rheumatoid arthritis: split or lump?
    Boers M
    Arthritis Rheum; 2008 Oct; 58(10):2925-7. PubMed ID: 18821696
    [No Abstract]   [Full Text] [Related]  

  • 6. Remission by composite scores in rheumatoid arthritis: are ankles and feet important?
    Kapral T; Dernoschnig F; Machold KP; Stamm T; Schoels M; Smolen JS; Aletaha D
    Arthritis Res Ther; 2007; 9(4):R72. PubMed ID: 17662115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
    Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
    J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical relevance of a prediction rule for disease outcome in patients with undifferentiated arthritis: comment on the article by van der Helm-van Mil et al.
    Visser H; Hazes JM; Luime J
    Arthritis Rheum; 2009 Jul; 60(7):2208-9; author reply 2209-10. PubMed ID: 19565508
    [No Abstract]   [Full Text] [Related]  

  • 10. Key randomized trials of single agents in early rheumatoid arthritis.
    van de Putte LB
    J Rheumatol Suppl; 2002 Nov; 66():13-9. PubMed ID: 12435164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treat-to-target and remission: current strategies in rheumatoid arthritis].
    Schneider M; Ostendorf B
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1761-5. PubMed ID: 22933202
    [No Abstract]   [Full Text] [Related]  

  • 12. How antirheumatic drugs protect joints from damage in rheumatoid arthritis.
    Schett G; Stach C; Zwerina J; Voll R; Manger B
    Arthritis Rheum; 2008 Oct; 58(10):2936-48. PubMed ID: 18821703
    [No Abstract]   [Full Text] [Related]  

  • 13. Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
    Cohen SB; Cohen MD; Cush JJ; Fleischmann RM; Mease PJ; Schiff MH; Simon LS; Weaver AL
    J Rheumatol Suppl; 2008 Feb; 81():4-30; quiz 31-4. PubMed ID: 19193621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.
    Wolfe F; Rasker JJ; Boers M; Wells GA; Michaud K
    Arthritis Rheum; 2007 Aug; 57(6):935-42. PubMed ID: 17665487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between clinimetric approach and German US7 score in rheumatoid arthritis patients treated with tocilizumab: a pilot study.
    Terenzi R; Santoboni G; Bartoloni E; Alunno A; Luccioli F; Gerli R
    Clin Exp Rheumatol; 2015; 33(3):445. PubMed ID: 25937244
    [No Abstract]   [Full Text] [Related]  

  • 16. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ
    Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using disease activity measures in an office-based practice.
    Bergman MJ
    J Clin Rheumatol; 2010 Mar; 16(2):96-7. PubMed ID: 20216131
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.